185 related articles for article (PubMed ID: 37982982)
1. Evaluating the Safety of an Educational Deprescribing Intervention: Lessons from the Optimize Trial.
Boyd CM; Shetterly SM; Powers JD; Weffald LA; Green AR; Sheehan OC; Reeve E; Drace ML; Norton JD; Maiyani M; Gleason KS; Sawyer JK; Maciejewski ML; Wolff JL; Kraus C; Bayliss EA
Drugs Aging; 2024 Jan; 41(1):45-54. PubMed ID: 37982982
[TBL] [Abstract][Full Text] [Related]
2. Deprescribing Education vs Usual Care for Patients With Cognitive Impairment and Primary Care Clinicians: The OPTIMIZE Pragmatic Cluster Randomized Trial.
Bayliss EA; Shetterly SM; Drace ML; Norton JD; Maiyani M; Gleason KS; Sawyer JK; Weffald LA; Green AR; Reeve E; Maciejewski ML; Sheehan OC; Wolff JL; Kraus C; Boyd CM
JAMA Intern Med; 2022 May; 182(5):534-542. PubMed ID: 35343999
[TBL] [Abstract][Full Text] [Related]
3. The OPTIMIZE patient- and family-centered, primary care-based deprescribing intervention for older adults with dementia or mild cognitive impairment and multiple chronic conditions: study protocol for a pragmatic cluster randomized controlled trial.
Bayliss EA; Shetterly SM; Drace ML; Norton J; Green AR; Reeve E; Weffald LA; Wright L; Maciejewski ML; Sheehan OC; Wolff JL; Gleason KS; Kraus C; Maiyani M; Du Vall M; Boyd CM
Trials; 2020 Jun; 21(1):542. PubMed ID: 32552857
[TBL] [Abstract][Full Text] [Related]
4. The MedSafer Study-Electronic Decision Support for Deprescribing in Hospitalized Older Adults: A Cluster Randomized Clinical Trial.
McDonald EG; Wu PE; Rashidi B; Wilson MG; Bortolussi-Courval É; Atique A; Battu K; Bonnici A; Elsayed S; Wilson AG; Papillon-Ferland L; Pilote L; Porter S; Murphy J; Ross SB; Shiu J; Tamblyn R; Whitty R; Xu J; Fabreau G; Haddad T; Palepu A; Khan N; McAlister FA; Downar J; Huang AR; MacMillan TE; Cavalcanti RB; Lee TC
JAMA Intern Med; 2022 Mar; 182(3):265-273. PubMed ID: 35040926
[TBL] [Abstract][Full Text] [Related]
5. A health-system-embedded deprescribing intervention targeting patients and providers to prevent falls in older adults (STOP-FALLS trial): study protocol for a pragmatic cluster-randomized controlled trial.
Balderson BH; Gray SL; Fujii MM; Nakata KG; Williamson BD; Cook AJ; Wellman R; Theis MK; Lewis CC; Key D; Phelan EA
Trials; 2023 May; 24(1):322. PubMed ID: 37170329
[TBL] [Abstract][Full Text] [Related]
6. Intervention design in cognitively impaired populations-Lessons learned from the OPTIMIZE deprescribing pragmatic trial.
Sheehan OC; Gleason KS; Bayliss EA; Green AR; Drace ML; Norton J; Reeve E; Shetterly SM; Weffald LA; Sawyer JK; Maciejewski ML; Kraus C; Maiyani M; Wolff J; Boyd CM
J Am Geriatr Soc; 2023 Mar; 71(3):774-784. PubMed ID: 36508725
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Deprescribing Medications Among Older Adults From End of Hospitalization Through Postacute Care: A Shed-MEDS Randomized Clinical Trial.
Vasilevskis EE; Shah AS; Hollingsworth EK; Shotwell MS; Kripalani S; Mixon AS; Simmons SF
JAMA Intern Med; 2023 Mar; 183(3):223-231. PubMed ID: 36745422
[TBL] [Abstract][Full Text] [Related]
9. Anticholinergic deprescribing interventions for reducing risk of cognitive decline or dementia in older adults with and without prior cognitive impairment.
Taylor-Rowan M; Alharthi AA; Noel-Storr AH; Myint PK; Stewart C; McCleery J; Quinn TJ
Cochrane Database Syst Rev; 2023 Dec; 12(12):CD015405. PubMed ID: 38063254
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of a multi-faceted intervention to deprescribe proton pump inhibitors in primary care: protocol for a population-based, pragmatic, cluster-randomized controlled trial.
Nguyen-Soenen J; Rat C; Gaultier A; Schirr-Bonnans S; Tessier P; Fournier JP
BMC Health Serv Res; 2022 Feb; 22(1):219. PubMed ID: 35177042
[TBL] [Abstract][Full Text] [Related]
11. Association of Deprescribing With Reduction in Mortality and Hospitalization: A Pragmatic Stepped-Wedge Cluster-Randomized Controlled Trial.
Kua CH; Yeo CYY; Tan PC; Char CWT; Tan CWY; Mak V; Leong IY; Lee SWH
J Am Med Dir Assoc; 2021 Jan; 22(1):82-89.e3. PubMed ID: 32423694
[TBL] [Abstract][Full Text] [Related]
12. Spread and scale of an electronic deprescribing software to improve health outcomes of older adults living in nursing homes: study protocol for a stepped wedge cluster randomized trial.
Nadeau ME; Henry JL; Lee TC; Bortolussi-Courval É; Goodine C; McDonald EG
Trials; 2021 Nov; 22(1):763. PubMed ID: 34727956
[TBL] [Abstract][Full Text] [Related]
13. GP-delivered medication review of polypharmacy, deprescribing, and patient priorities in older people with multimorbidity in Irish primary care (SPPiRE Study): A cluster randomised controlled trial.
McCarthy C; Clyne B; Boland F; Moriarty F; Flood M; Wallace E; Smith SM;
PLoS Med; 2022 Jan; 19(1):e1003862. PubMed ID: 34986166
[TBL] [Abstract][Full Text] [Related]
14. Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis.
Reeve J; Maden M; Hill R; Turk A; Mahtani K; Wong G; Lasserson D; Krska J; Mangin D; Byng R; Wallace E; Ranson E
Health Technol Assess; 2022 Jul; 26(32):1-148. PubMed ID: 35894932
[TBL] [Abstract][Full Text] [Related]
15. Family Conferences to Facilitate Deprescribing in Older Outpatients With Frailty and With Polypharmacy: The COFRAIL Cluster Randomized Trial.
Mortsiefer A; Löscher S; Pashutina Y; Santos S; Altiner A; Drewelow E; Ritzke M; Wollny A; Thürmann P; Bencheva V; Gogolin M; Meyer G; Abraham J; Fleischer S; Icks A; Montalbo J; Wiese B; Wilm S; Feldmeier G
JAMA Netw Open; 2023 Mar; 6(3):e234723. PubMed ID: 36972052
[TBL] [Abstract][Full Text] [Related]
16. Professional, structural and organisational interventions in primary care for reducing medication errors.
Khalil H; Bell B; Chambers H; Sheikh A; Avery AJ
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD003942. PubMed ID: 28977687
[TBL] [Abstract][Full Text] [Related]
17. Direct-to-consumer strategies to promote deprescribing in primary care: a pilot study.
Linsky AM; Kressin NR; Stolzmann K; Pendergast J; Rosen AK; Bokhour BG; Simon SR
BMC Prim Care; 2022 Mar; 23(1):53. PubMed ID: 35317734
[TBL] [Abstract][Full Text] [Related]
18. The value of deprescribing in older adults with dementia: a narrative review.
Sawan MJ; Moga DC; Ma MJ; Ng JC; Johnell K; Gnjidic D
Expert Rev Clin Pharmacol; 2021 Nov; 14(11):1367-1382. PubMed ID: 34311630
[No Abstract] [Full Text] [Related]
19. Decreasing polypharmacy in older adults with cancer: A pilot cluster-randomized trial protocol.
Ramsdale E; Mohamed M; Holmes HM; Zubkoff L; Bauer J; Norton SA; Mohile S
J Geriatr Oncol; 2024 Mar; 15(2):101687. PubMed ID: 38302299
[TBL] [Abstract][Full Text] [Related]
20. Deprescribing in older adults with polypharmacy.
Hung A; Kim YH; Pavon JM
BMJ; 2024 May; 385():e074892. PubMed ID: 38719530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
